Biological
Pandemrix clinical trials
- studies test it
- 8
- open now
- 0
- in phase 3
- 1
- first study started
- 2007
How studies write it
Studies that test it under each name
Name
Studies by the year they started
8 studies that test it; most in 2009 (5)
| Year | Studies |
|---|---|
| 2007 | 1 |
| 2009 | 5 |
| 2010 | 1 |
| 2016 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 3
- Phase 3
- 1
- Phase 4
- 1
- No phase
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 4
GlaxoSmithKline (4) · University of Bergen (1) · University of Oxford (1) · Erasme University Hospital (1) · Hadassah Medical Organization (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses pandemrix is read from its arms, and is right about nine times in ten.
Testing it · 8
- Studies of Pandemic Influenza (H1N1) 2009 Vaccine in BergenCompletedNot applicableUniversity of BergenNCT01003288Written as Adjuvanted influenza H1N1split virion vaccine
- A Dose Ranging Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' GSK1557484A Vaccine in Children 6 to Less Than 36 Months of AgeCompletedPhase 2GlaxoSmithKlineNCT02719743Written as Influenza A (H5N1) Virus monovalent vaccine (GSK1557484A).
- Immunogenicity and Safety of Vaccine GSK2340272A (H1N1) and GSK Biologicals Fluarix™ Vaccine When Co-administered in ElderlyCompletedPhase 2GlaxoSmithKlineNCT00968890Written as Pandemrix (Influenza vaccine GSK2340272A)
- Study to Evaluate the Safety and Immune Response of Two-Doses of Candidate Influenza Vaccine GSK 1557484A in AdultsCompletedPhase 1GlaxoSmithKlineNCT00510874Written as Pandemrix ™
- Evaluation of the Immune Response and the Safety of a Pandemic Influenza Candidate Vaccine (H1N1)CompletedPhase 3GlaxoSmithKlineNCT00971425Written as Pandemrix (GSK investigational influenza GSK2340272A vaccine)
- Swine Flu (Novel Influenza A H1N1) Vaccine StudyCompletedPhase 2University of OxfordNCT00980850Written as GlaxoSmithKline Novel Influenza A H1N1 Split Virion Vaccine
- Influenza A/H1N1/2009-adjuvanted Vaccine in Renal Disease PatientsCompletedPhase 4Erasme University HospitalNCT01298102Written as Influenza A/H1N1 2009-AS03 adjuvanted (Pandemrix)
- Assessment of Safety and Immunogenicity of Intradermal Unadjuvanted Portion of Pandemrix® Via a Microneedle Device With Intramuscular Adjuvanted Pandemrix® as ReferenceStatus unknownNot applicableHadassah Medical OrganizationNCT01039623Written as Pandemrix® (H1N1 pandemic influenza)